Concomitant chemoradiotherapy for muscle-invasive bladder cancer: The way forward for bladder preservation?

Clinical Oncology

Volumn 17, Issue 3, 2005, Pages 160-166

  Sherwood, B T ^a   Jones, G D D ^a   Mellon, J K ^a   Kockelberg, R C ^a   Steward, W P ^a   Symonds, R Paul ^a,b  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Bladder cancer; Bladder preservation; Chemotherapy; Radiotherapy

Indexed keywords

CISPLATIN; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; FLUOROURACIL; GEFITINIB; METHOTREXATE; MITOMYCIN; TYROSINE KINASE RECEPTOR; VINBLASTINE;

ANEMIA; ARTICLE; BLADDER CANCER; BLADDER FUNCTION; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER INVASION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL STUDY; CLINICAL TRIAL; CYSTECTOMY; DRUG TARGETING; FOLLOW UP; HEALTH PROGRAM; HUMAN; LEUKOPENIA; MEDICAL LITERATURE; MUSCLE METASTASIS; NEPHROTOXICITY; NONHUMAN; ORGAN PRESERVATION; PRIORITY JOURNAL; PROTEIN TARGETING; QUALITY OF LIFE; TRANSURETHRAL RESECTION;

ANTINEOPLASTIC AGENTS; CLINICAL TRIALS; COMBINED MODALITY THERAPY; HUMANS; RADIOTHERAPY; TREATMENT OUTCOME; URINARY BLADDER; URINARY BLADDER NEOPLASMS; UROLOGIC SURGICAL PROCEDURES;

EID: 16344375473     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2004.08.011     Document Type: Article

References (59)

1. M.R. Feneley M. Schoenberg Bladder-sparing strategies for transitional cell carcinoma Urology 56 2000 549-560
2. H.L. Kim G.D. Steinberg Complications of cystectomy in patients with a history of pelvic radiation Urology 58 2001 557-560
3. F. Pagano P. Bassi T.P. Galetti et al. Results of contemporary radical cystectomy for invasive bladder cancer: A clinicopathological study with an emphasis on the inadequacy of the Tumor, Nodes and Metastases classification J Urol 145 1991 45-50
4. J.P. Stein G. Lieskovsky R. Cote et al. Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1054 patients J Clin Oncol 19 2001 666-675
5. W. Duncan P.M. Quilty The results of a series of 963 patients with transitional-cell carcinoma of the urinary bladder primarily treated by radical megavoltage X-ray therapy Radiother Oncol 7 1986 299-310
6. W.U. Shipley M.A. Rose T.L. Perrone C.M. Mannix N.M. Heney G.R. Prout Full-dose irradiation for patients with invasive bladder carcinoma: clinical and histological factors prognostic of improved survival J Urol 134 1985 679-683
7. P.M. Quilty W. Duncan Primary radical radiotherapy for T3 transitional cell cancer of the bladder: An analysis of survival and control Int J Radiat Oncol Biol Phys 12 1986 853-860
8. E.E. Vokes R.R. Weichselbaum Concomitant chemotherapy: Rational and clinical experience in patients with solid tumours J Clin Oncol 8 1990 911-934
9. I.F. Tannock G. Browman Lack of evidence for a role of chemotherapy in the routine management of locally advanced head and neck cancer J Clin Oncol 4 1986 1121-1126
10. H. Abol-Enein A.V. Bono M. Boyer et al. Neoadjuvant chemotherapy in invasive bladder cancer: A systematic review and meta-analysis Lancet 361 2003 1927-1934
11. A.C. Begg Cisplatin and radiation: Interaction probabilities and therapeutic possibilities Int J Radiat Oncol Biol Phys 19 1990 1183-1189
12. L.X. Yang E.B. Douple J.A. Ohara H.J. Wang Production of DNA double strand breaks by interactions between carboplatin and radiation: A potential mechanism for radiopotentiation Radiat Res 143 1995 309-315
13. L. Dewit Y. Oussoren H. Bartelink H.D. Thames The effect of cis-diamminedichloroplatinum(Ii) on radiation: Damage in mouse rectum after fractionated irradiation Radiother Oncol 16 1989 121-128
14. L. Dewit Combined treatment of radiation and cis-diamminedichloroplatinum(Ii): A review of experimental and clinical data Int J Radiat Oncol Biol Phys 13 1987 403-426
15. A.P. Kyriazis A. Yagoda J.G. Kereiakes A.A. Kyriazis W.F. Whitmore Experimental studies on the radiation-modifying effect of cis-diamminedichloroplatinum-Ii (Ddp) in human bladder transitional cell carcinomas grown in nude mice Cancer 52 1983 452-457
16. C. Mothersill C.B. Seymour A. Cusack A. Obrien M. Butler The effect of radiation and cytotoxic platinum compounds on the growth of normal and tumor bladder explant cultures Acta Oncol 29 1990 179-184
17. J.A. Green J.M. Kirwan J.F. Tierney et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: A systematic review and meta-analysis Lancet 358 2001 781-786
18. P.G. Rose Chemoradiotherapy for cervical cancer Eur J Cancer 38 2002 270-278
19. H. Bartelink F. Roelofsen F. Eschwege et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: Results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups J Clin Oncol 15 1997 2040-2049
20. S.J. Arnott D. Cunningham J. Gallagher et al. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin Lancet 348 1996 1049-1054
21. J.M.A. Northover Epidermoid cancer of the anus: The surgeon retreats J R Soc Med 84 1991 389-390
22. J.S. Cooper M.D. Guo A. Herskovic et al. Chemoradiotherapy of locally advanced esophageal cancer: Long-term follow-up of a prospective randomized trial (RTOG 85-01) JAMA 281 1999 1623-1627
23. M.S. Soloway M. Ikard M. Scheinberg J. Evans Concurrent radiation and cisplatin in the treatment of advanced bladder cancer: A preliminary report J Urol 128 1982 1031-1033
24. W.U. Shipley D.S. Kaufman E. Zehr et al. Selective bladder preservation by combined modality protocol treatment: Long-term outcomes of 190 patients with invasive bladder cancer Urology 60 2002 62-67
25. C. Rodel G.G. Grabenbauer R. Kuhn et al. Combined-modality treatment and selective organ preservation in invasive bladder cancer: Long-term results J Clin Oncol 20 2002 3061-3071
26. F. Arias M.A. Dominguez E. Martinez et al. Chemoradiotherapy for muscle invading bladder carcinoma. Final report of a single institutional organ-sparing program Int J Radiat Oncol Biol Phys 47 2000 373-378
27. W. Tester R. Caplan J. Heaney et al. Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802 J Clin Oncol 14 1996 119-126
28. W.U. Shipley K.A. Winter D.S. Kaufman et al. Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: Initial results of Radiation Therapy Oncology Group 89-03 J Clin Oncol 16 1998 3576-3583
29. J. Dunst R. Sauer K.M. Schrott R. Kuhn C. Wittekind A. Altendorfhofmann Organ-sparing treatment of advanced bladder cancer: A 10-year experience Int J Radiat Oncol Biol Phys 30 1994 261-266
30. A.B. Einstein M. Wolf K.R. Halliday et al. Combination transurethral resection, systemic chemotherapy, and pelvic radiotherapy for invasive (t2-t4) bladder cancer unsuitable for cystectomy: A phase I/II Southwestern Oncology Group study Urology 47 1996 652-657
31. G. Fellin U. Graffer A. Bolner G. Ambrosini O. Caffo L. Luciani Combined chemotherapy and radiation with selective organ preservation for muscle-invasive bladder carcinoma. A single-institution phase II study Br J Urol 80 1997 44-49
32. R.W. Given J.T. Parsons D. McCarley Z. Wajsman Bladder-sparing multimodality treatment of muscle-invasive bladder cancer: A 5-year follow-up Urology 46 1995 499-504
33. M. Housset C. Maulard Y. Chretien et al. Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: A prospective study J Clin Oncol 11 1993 2150-2157
34. L.A. Kachnic D.S. Kaufman N.M. Heney et al. Bladder preservation by combined modality therapy for invasive bladder cancer J Clin Oncol 15 1997 1022-1029
35. D.S. Kaufman W.U. Shipley P.P. Griffin N.M. Heney A.F. Althausen J.T. Efird Selective bladder preservation by combination treatment of invasive bladder cancer N Engl J Med 329 1993 1377-1382
36. M. Orsatti V. Vitale A. Curotto et al. Alternating chemo-radiotherapy in bladder cancer: A conservative approach Eur J Cancer 31A 1995 1161
37. V. Serretta G. Lo Greco C. Pavone M. Pavone-Macaluso The fate of patients with locally advanced bladder cancer treated conservatively with neoadjuvant chemotherapy, extensive transurethral resection and radiotherapy: 10-year experience J Urol 159 1998 1187-1190
38. W. Tester R. Caplan J. Heaney et al. Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802 J Clin Oncol 14 1996 119-126
39. B. Vikram S. Malamud P. Silverman H. Hecht H. Grabstald A pilot-study of chemotherapy alternating with twice-a-day accelerated radiation-therapy as an alternative to cystectomy in muscle infiltrating (stages t2 and t3) cancer of the bladder: Preliminary-results J Urol 151 1994 602-604
40. A.L. Zietman W.U. Shipley D.S. Kaufman et al. A phase I/II trial of transurethral surgery combined with concurrent cisplatin, 5-fluorouracil and twice daily radiation followed by selective bladder preservation in operable patients with muscle invading bladder cancer J Urol 160 1998 1673-1677
41. C.M.L. Coppin M.K. Gospodarowicz K. James et al. Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation J Clin Oncol 14 1996 2901-2907
42. K. Mellon C. Wright P. Kelly C.H.W. Horne D.E. Neal Long-term outcome related to epidermal growth-factor receptor status in bladder-cancer J Urol 153 1995 919-925
43. P.L. Nguyen P.E. Swanson W. Jaszcz et al. Expression of epidermal growth-factor receptor in invasive transitional-cell carcinoma of the urinary bladder: A multivariate survival analysis Am J Clin Pathol 101 1994 166-176
44. G. Lammering K. Valerie P.S. Lin et al. Radiosensitization of malignant glioma cells through overexpression of dominant-negative epidermal growth factor receptor Clin Cancer Res 7 2001 682-690
45. F. Ciardiello G. Tortora Anti-epidermal growth factor receptor drugs in cancer therapy Expert Opinion Investig Drugs 11 2002 755-768
46. G. Dalbagni E. Genega M. Hashibe et al. Cystectomy for bladder cancer: A contemporary series J Urol 165 2001 1111-1116
47. H. Wijkstrom U. Norming M. Lagerkvist B. Nilsson I. Naslund P. Wiklund Evaluation of clinical staging before cystectomy in transitional cell bladder carcinoma: A long-term follow-up of 276 consecutive patients Br J Urol 81 1998 686-691
48. M.K. Gospodarowicz N.V. Hawkins G.A. Rawlings et al. Radical radiotherapy for muscle invasive transitional cell carcinoma of the bladder: Failure analysis J Urol 142 1989 1448-1454
49. A.B. Jacobsen S. Lunde S. Ous et al. T2-T3 bladder carcinomas treated with definitive radiotherapy with emphasis on flow cytometric DNA ploidy values Int J Radiat Oncol Biol Phys 17 1989 923-929
50. A. Pollack G.K. Zagars D.A. Swanson Muscle-invasive bladder cancer treated with external-beam radiotherapy: Prognostic factors Int J Radiat Oncol Biol Phys 30 1994 267-277
51. D.M. Brizel S.P. Scully J.M. Harrelson et al. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma Cancer Res 56 1996 941-943
52. B. Fertil E.P. Malaise Inherent cellular radiosensitivity as a basic concept for human tumor radiotherapy Int J Radiat Oncol Biol Phys 7 1981 621-629
53. P.C. Lara A. Rey C. Santana et al. The role of ki67 proliferation assessment in predicting local control in bladder cancer patients treated by radical radiation therapy Radiother Oncol 49 1998 163-167
54. D.T. Danesi G. Arcangeli E. Cruciani et al. Combined treatment of invasive bladder carcinoma with transurethral resection, induction chemotherapy, and radical radiotherapy plus concomitant protracted infusion of cisplatin and 5-fluorouracil: A phase I study Cancer 80 1997 1464-1471
55. S.A. Hussain D.D. Moffitt J.G. Glaholm D. Peake D.M.A. Wallace N.D. James A phase I-II study of synchronous chemoradiotherapy for poor prognosis locally advanced bladder cancer Ann Oncol 12 2001 929-935
56. D.S. Kaufman W.U. Shipley P.P. Griffin N.M. Heney A.F. Althausen J.T. Efird Selective bladder preservation by combination treatment of invasive bladder cancer N Engl J Med 329 1993 1377-1382
57. M. Orsatti A. Curotto L. Canobbio et al. Alternating chemoradiotherapy in bladder-cancer - a conservative approach Int J Radiat Oncol Biol Phys 33 1 1995 173-178
58. B. Vikram S. Malamud P. Silverman H. Hecht H. Grabstald Alternating chemoradiotherapy for muscle-infiltrating bladder cancer Int J Radiat Oncol Biol Phys 27 1993 218
59. A.L. Zietman D.S. Kaufman W.U. Shipley et al. A phase I/II trial of transurethral surgery plus cisplatin and radiation therapy followed by either selective bladder preservation or radical cystectomy for patients with muscle-invading bladder cancer but without hydronephrosis Int J Radiat Oncol Biol Phys 39 1997 155